4.3 Article

2009 White Paper on Recent Issues in Regulated Bioanalysis from The 3rd Calibration and Validation Group Workshop

期刊

BIOANALYSIS
卷 2, 期 1, 页码 53-68

出版社

FUTURE SCI LTD
DOI: 10.4155/BIO.09.134

关键词

-

资金

  1. US FDA
  2. Health Canada TPD
  3. UK MHRA
  4. European Bioanalysis Forum (EBF)
  5. Workshop sustaining sponsors: Acanthus Research
  6. Agilent Technologies
  7. Algorithme Pharma
  8. Anapharm
  9. Cantest
  10. CEDRA
  11. Chemtos
  12. Lachman Consultants
  13. MDS Pharma Services
  14. PPD
  15. Prevalere Life Sciences
  16. Synfine Research
  17. Waters
  18. Media Partner: Future Science Group

向作者/读者索取更多资源

The 3rd Calibration and Validation Group Workshop on Recent Issues in Regulated Bioanalysis was organized by the Calibration and Validation Group as a I.5-day full immersion workshop for contract research organizations, pharmaceutical companies and regulatory agencies to discuss several 'hot' topics concerning bioanalytical issues and regulatory challenges. A consensus was reached among panelists and attendees on many points regarding method validation of small molecules.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据